Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

High-throughput Oligopaint screen identifies druggable 3D genome regulators

ABSTRACT: High-throughput Oligopaint screen identifies druggable 3D genome regulators

PROVIDER: PRJNA820829 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23041370_1.fastq.gz	Fastqsanger.gz
	SRR23041370_2.fastq.gz	Fastqsanger.gz
	SRR23041371_1.fastq.gz	Fastqsanger.gz
	SRR23041371_2.fastq.gz	Fastqsanger.gz
	SRR23041372_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 35

Similar Datasets

High-throughput Oligopaint screen identifies druggable 3D genome regulators

Project description:Although the molecular rules governing chromatin folding are being quickly elucidated, relatively few proteins regulating genome organization have been identified. To address this, we developed HiDRO (high-throughput labeling of DNA or RNA with optimized Oligopaint probes). Combined with automated image analysis, we used HiDRO to conduct a novel FISH-based screen of ~3,000 druggable genes that alter inter-TAD interactions. We isolated several enzymes that alter the integrity of architectural boundaries, including our top hit Glycogen synthase kinase alpha (GSK3A). We demonstrated using chemical and genetic inhibition that this ubiquitously expressed kinase enhances chromatin looping by regulating the chromatin binding of cohesin regulators. Finally, our data demonstrate that a GSK3A inhibitor can rescue both chromatin misfolding and gene misexpression at a sensitive locus after partial cohesin loss. These results illustrate a noncanonical role for GSK3A in cohesin regulation and highlight the broader utility of HiDRO-based screening to identify novel genome organizing factors.

2023-05-05 | GSE199607 | GEO

High-throughput Oligopaint screen identifies druggable 3D genome regulators.

Project description:The human genome functions as a three-dimensional chromatin polymer, driven by a complex collection of chromosome interactions1-3. Although the molecular rules governing these interactions are being quickly elucidated, relatively few proteins regulating this process have been identified. Here, to address this gap, we developed high-throughput DNA or RNA labelling with optimized Oligopaints (HiDRO)-an automated imaging pipeline that enables the quantitative measurement of chromatin interactions in single cells across thousands of samples. By screening the human druggable genome, we identified more than 300 factors that influence genome folding during interphase. Among these, 43 genes were validated as either increasing or decreasing interactions between topologically associating domains. Our findings show that genetic or chemical inhibition of the ubiquitous kinase GSK3A leads to increased long-range chromatin looping interactions in a genome-wide and cohesin-dependent manner. These results demonstrate the importance of GSK3A signalling in nuclear architecture and the use of HiDRO for identifying mechanisms of spatial genome organization.

| S-EPMC11305015 | biostudies-literature

An RNA interference screen identifies druggable regulators of MeCP2 stability.

Project description:Alterations in gene dosage due to copy number variation are associated with autism spectrum disorder, intellectual disability (ID), and other psychiatric disorders. The nervous system is so acutely sensitive to the dose of methyl-CpG-binding protein 2 (MeCP2) that even a twofold change in MeCP2 protein-either increased or decreased-results in distinct disorders with overlapping features including ID, autistic behavior, and severe motor dysfunction. Rett syndrome is caused by loss-of-function mutations in MECP2, whereas duplications spanning the MECP2 locus result in MECP2 duplication syndrome (MDS), which accounts for ~1% of X-linked ID. Despite evidence from mouse models that restoring MeCP2 can reverse the course of disease, there are currently no U.S. Food and Drug Administration-approved therapies available to clinically modulate MeCP2 abundance. We used a forward genetic screen against all known human kinases and phosphatases to identify druggable regulators of MeCP2 stability. Two putative modulators of MeCP2, HIPK2 (homeodomain-interacting protein kinase 2) and PP2A (protein phosphatase 2A), were validated as stabilizers of MeCP2 in vivo. Further, pharmacological inhibition of PP2A in vivo reduced MeCP2 in the nervous system and rescued both overexpression and motor abnormalities in a mouse model of MDS. Our findings reveal potential therapeutic targets for treating disorders of altered MECP2 dosage.

| S-EPMC5736385 | biostudies-literature

CRISPR screen for NMD regulators

Project description:CRISPR screen for NMD regulators

| PRJNA602918 | ENA

CRISPR screen targeting druggable genes in 4T1 mouse cells

Project description:CRISPR screen targeting druggable genes in 4T1 mouse cells

| PRJEB46362 | ENA

Identify proinsulin regulators using CRISPR screen and mouse genetics [CRISPR screen]

Project description:Identify proinsulin regulators using CRISPR screen and mouse genetics [CRISPR screen]

| PRJNA1030057 | ENA

Genome-wide base editor screen identifies regulators of protein abundance in yeast

Project description:Proteins are key molecular players in a cell, and their abundance is extensively regulated not just at the level of gene expression but also post-transcriptionally. Here, we describe a genetic screen in yeast that enables systematic characterization of how protein abundance regulation is encoded in the genome. The screen combines a CRISPR/Cas9 base editor to introduce point mutations with fluorescent tagging of endogenous proteins to facilitate a flow-cytometric readout. We first benchmarked base editor performance in yeast with individual gRNAs as well as in positive and negative selection screens. We then examined the effects of 16,452 genetic perturbations on the abundance of eleven proteins representing a variety of cellular functions. We uncovered hundreds of regulatory relationships, including a novel link between the GAPDH isoenzymes Tdh1/2/3 and the Ras/PKA pathway. Many of the identified regulators are specific to one of the eleven proteins, but we also found genes that, upon perturbation, affected the abundance of most of the tested proteins. While the more specific regulators usually act transcriptionally, broad regulators often have roles in protein translation. Overall, our novel screening approach provides unprecedented insights into the components, scale and connectedness of the protein regulatory network.

2022-11-07 | PXD029363 | Pride

In vivo CRISPR screening reveals druggable regulators of mammalian tissue regeneration

Project description:In vivo CRISPR screening reveals druggable regulators of mammalian tissue regeneration

| PRJNA761087 | ENA

CRISPR screen to identify regulators of neuronal differentiation

Project description:CRISPR screen to identify regulators of neuronal differentiation

| PRJEB54698 | ENA

Genome-wide CRISPR screen to identify CD58 regulators

Project description:Genome-wide CRISPR screen to identify CD58 regulators

| PRJNA934388 | ENA